Concepedia

Sven Walderich

SW

Statistics

Publications

3

Citations

96

H-Index

3

Active since

2020

Affiliations

Cornell University(Current)

Memorial Sloan Kettering Cancer Center

Sven Walderich is an author at Cornell University specializing in oncology, medicine, and pharmacology.

Publications per year

2020–2024

3

Publications

3

Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial

Dmitriy Zamarin, Sven Walderich, Aliya Holland et al. · Journal for ImmunoTherapy of Cancer · 2020 · 54 citations · Full text

Medicine, Oncology, Pharmacology +17

Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignancies

Marina Stasenko, Evan Smith, Oladapo Yeku et al. · Scientific Reports · 2021 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17

Interferon response and epigenetic modulation by <i>SMARCA4</i> mutations drive ovarian tumor immunogenicity

Melica Nourmoussavi Brodeur, Higinio Dopeso, Yingjie Zhu et al. · Science Advances · 2024 · 10 citations · Full text

Medicine, Immunology, Oncology +17

1–3 of 3